CLINICAL_TRIALS
trial_result
· 2019-03-21
Clinical Trial Update: Use of the VisuMax™ Femtosecond Laser [Phase 1]
Summary
Phase 1 clinical trial update on the VisuMax femtosecond laser for myopia; the study is completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Carl Zeiss Meditec, Inc. | Conditions: Myopia | Phase 1 | Status: COMPLETED | Results posted: 2019-03-21